Discover how allogeneic CAR-T developers and manufacturers are producing the latest advanced therapies in this free infographic.
As part of our Spotlight on allogeneic CAR-T, we surveyed the regenerative medicine community to find out what allogeneic CAR-T therapies they were developing, the challenges they were facing and how they thought the field might evolve in the future. What is the most common cell culture media used? Do manufacturers want more standardized raw materials, more automated processes or both?
Find out in the infographic below. If you want to learn more about allogeneic CAR-T, check out our spotlight. Plus, register for our live discussion where a panel of international experts from CellGenix, Lonza and UCL will share their insights into the results of the survey, offer their recommendations for overcoming common obstacles and make their predictions for the future of the field. Register now>>